The difference in the inhibitory mechanisms of papaverine on vascular and intestinal smooth muscles

被引:31
作者
Kaneda, T [1 ]
Shimizu, K [1 ]
Nakajyo, S [1 ]
Urakawa, N [1 ]
机构
[1] Nippon Vet & Anim Sci Univ, Div Vet Pharmacol, Musashino, Tokyo 180, Japan
关键词
papaverine; cyclic nucleotide; oxidative metabolism; aorta; ileum;
D O I
10.1016/S0014-2999(98)00479-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Papaverine (0.3-100 mu M) more potently inhibited phenylephrine (1 mu M)-induced contraction than 65 mM K+-induced contraction of the aorta, while it equally inhibited contractions induced by 65 mM K+ and carbachol (1 mu M) in ileal smooth muscle. In phenylephrine-treated aorta, papaverine (1-10 mu M) increased the cAMP and cGMP content. However, in carbachol-treated ileum, 30 mu M papaverine partially increased the cAMP content while it maximally relaxed the preparation. In fura2-loaded aorta, papaverine (0.3-10 mu M) inhibited both the contraction and the increase in intracellular Ca2+ level ([Ca2+](i)) induced by phenylephrine in parallel. However, papaverine inhibited carbachol-induced contraction with only a small decrease in [Ca2+](i). Papaverine (1-30 mu M) inhibited the carbachol-induced increase in oxidized flavoproteins, an indicator of increased mitochondrial oxidative phosphorylation, in ileal smooth muscle whereas it did not change the phenylephrine-induced increase in the aorta. These results suggest that papaverine inhibits smooth muscle contraction mainly by the accumulation of cAMP and/or cGMP due to the inhibition of phosphodiesterase in the aorta whereas, in ileal smooth muscle, papaverine inhibits smooth muscle contraction mainly by the inhibition of mitochondrial respiration. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 31 条
[1]  
ABE A, 1989, J PHARMACOL EXP THER, V249, P895
[2]  
HAEUSLER G, 1975, VASCULAR NEUROEFFECT, P232
[3]  
HARRIS AL, 1989, J PHARMACOL EXP THER, V251, P199
[4]   DIBUTYRYL-CYCLIC-AMP AND FORSKOLIN INHIBIT PHOSPHATIDYLINOSITOL HYDROLYSIS CA-2+ INFLUX AND CONTRACTION IN VASCULAR SMOOTH-MUSCLE [J].
HEE, YA ;
SEUNG, EK ;
KI, CC ;
KARAKI, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 59 (02) :263-265
[5]  
IGUCHI M, 1992, J PHARMACOL EXP THER, V263, P194
[6]  
INAMOTO N, 1974, EUR J PHARMACOL, V26, P73
[7]  
ISHIDA Y, 1984, JPN J PHARMACOL, V36, pP178
[8]   Effects of various selective phosphodiesterase inhibitors on muscle contractility in guinea pig ileal longitudinal smooth muscle [J].
Kaneda, T ;
Shimizu, K ;
Nakajyo, S ;
Urakawa, N .
JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 75 (01) :77-85
[9]   EFFECTS OF SODIUM-NITROPRUSSIDE ON CYTOSOLIC CALCIUM LEVEL IN VASCULAR SMOOTH-MUSCLE [J].
KARAKI, H ;
SATO, K ;
OZAKI, H ;
MURAKAMI, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 156 (02) :259-266
[10]  
KARAKI H, 1984, GASTROENTEROLOGY, V87, P960